Balchem Corporation BL9B.F Stock
Balchem Corporation Price Chart
Balchem Corporation BL9B.F Financial and Trading Overview
Balchem Corporation stock price | 138.7 EUR |
Previous Close | 122.9 EUR |
Open | 122.8 EUR |
Bid | 122.7 EUR x 20000 |
Ask | 126.2 EUR x 20000 |
Day's Range | 122.7 - 122.8 EUR |
52 Week Range | 107.3 - 142.4 EUR |
Volume | 4 EUR |
Avg. Volume | 6 EUR |
Market Cap | 3.96B EUR |
Beta (5Y Monthly) | 0.703873 |
PE Ratio (TTM) | 43.35689 |
EPS (TTM) | 3.12 EUR |
Forward Dividend & Yield | 0.66 (0.53%) |
Ex-Dividend Date | December 23, 2022 |
1y Target Est | 150.75 EUR |
BL9B.F Valuation Measures
Enterprise Value | 4.35B EUR |
Trailing P/E | 43.35689 |
Forward P/E | 29.709442 |
PEG Ratio (5 yr expected) | 1.63 |
Price/Sales (ttm) | 4.185087 |
Price/Book (mrq) | 4.062107 |
Enterprise Value/Revenue | 4.598 |
Enterprise Value/EBITDA | 22.182 |
Trading Information
Balchem Corporation Stock Price History
Beta (5Y Monthly) | 0.703873 |
52-Week Change | 16.30% |
S&P500 52-Week Change | 20.43% |
52 Week High | 142.4 EUR |
52 Week Low | 107.3 EUR |
50-Day Moving Average | 116.13 EUR |
200-Day Moving Average | 123.2 EUR |
BL9B.F Share Statistics
Avg. Volume (3 month) | 6 EUR |
Avg. Daily Volume (10-Days) | 0 EUR |
Shares Outstanding | 32.23M |
Float | 31.94M |
Short Ratio | N/A |
% Held by Insiders | 0.93% |
% Held by Institutions | 91.63% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0.71 |
Trailing Annual Dividend Yield | 0.57% |
5 Year Average Dividend Yield | 48.00% |
Payout Ratio | 0.23200001 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 10.47% |
Operating Margin (ttm) | 15.10% |
Gross Margin | 29.82% |
EBITDA Margin | 20.72% |
Management Effectiveness
Return on Assets (ttm) | 6.32% |
Return on Equity (ttm) | 10.73% |
Income Statement
Revenue (ttm) | 946.03M EUR |
Revenue Per Share (ttm) | 29.54 EUR |
Quarterly Revenue Growth (yoy) | 1.60% |
Gross Profit (ttm) | 280.45M EUR |
EBITDA | 196.09M EUR |
Net Income Avi to Common (ttm) | 99.15M EUR |
Diluted EPS (ttm) | 2.83 |
Quarterly Earnings Growth (yoy) | -21.50% |
Balance Sheet
Total Cash (mrq) | 60.93M EUR |
Total Cash Per Share (mrq) | 1.89 EUR |
Total Debt (mrq) | 449.88M EUR |
Total Debt/Equity (mrq) | 46.22 EUR |
Current Ratio (mrq) | 2.88 |
Book Value Per Share (mrq) | 30.206 |
Cash Flow Statement
Operating Cash Flow (ttm) | 166.35M EUR |
Levered Free Cash Flow (ttm) | 69.59M EUR |
Profile of Balchem Corporation
Country | Germany |
State | NJ |
City | Montvale |
Address | 5 Paragon Drive |
ZIP | 07645 |
Phone | 845 326 5600 |
Website | https://www.balchem.com |
Industry | Specialty Chemicals |
Sector(s) | Basic Materials |
Full Time Employees | 1331 |
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment offers ethylene oxide primarily for use in the health care industry; single use canisters for sterilizing re-usable devices; and ammonia. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was incorporated in 1967 and is headquartered in Montvale, New Jersey.
Q&A For Balchem Corporation Stock
What is a current BL9B.F stock price?
Balchem Corporation BL9B.F stock price today per share is 138.7 EUR.
How to purchase Balchem Corporation stock?
You can buy BL9B.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Balchem Corporation?
The stock symbol or ticker of Balchem Corporation is BL9B.F.
Which industry does the Balchem Corporation company belong to?
The Balchem Corporation industry is Specialty Chemicals.
How many shares does Balchem Corporation have in circulation?
The max supply of Balchem Corporation shares is 32.27M.
What is Balchem Corporation Price to Earnings Ratio (PE Ratio)?
Balchem Corporation PE Ratio is 44.45512800 now.
What was Balchem Corporation earnings per share over the trailing 12 months (TTM)?
Balchem Corporation EPS is 3.12 EUR over the trailing 12 months.
Which sector does the Balchem Corporation company belong to?
The Balchem Corporation sector is Basic Materials.